063160.KS
CKD Bio Corp.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 13,600.00
−0.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.62x
- Price / sales
- 0.47x
- Price / cash flow
- 74.14x
Enterprise value
- Enterprise value
- KRW 222.0B
- EV / sales
- 1.40x
- EV / EBITDA
- 25.99x
- EV / EBIT
- -27.51x
- Market cap
- KRW 74.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026